The increase in CD8_Pro and reduction in their precursor CD8_Memory cells might partially indicate stronger CD8+ T cell responses in COVID-19 groups with severe disease and encephalopathy patients, resulting in potential pathogenic injury. The gene discussed is CD8A; the disease is Encephalopathy.